|
MYO9A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.437450E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.314500E-02 |
| Normal-vs-Stage2 |
5.384000E-03 |
| Normal-vs-Stage3 |
3.38370000019239E-07 |
| Normal-vs-Stage4 |
6.20579999610626E-08 |
| Stage1-vs-Stage2 |
1.499550E-01 |
| Stage1-vs-Stage3 |
3.81689999999768E-05 |
| Stage1-vs-Stage4 |
1.64425999999995E-05 |
| Stage2-vs-Stage3 |
1.528160E-01 |
| Stage2-vs-Stage4 |
3.185600E-02 |
| Stage3-vs-Stage4 |
2.728000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.643300E-04 |
| Normal-vs-AfricanAmerican |
1.208130E-04 |
| Normal-vs-Asian |
8.845800E-01 |
| Caucasian-vs-AfricanAmerican |
1.139760E-01 |
| Caucasian-vs-Asian |
2.501600E-01 |
| AfricanAmerican-vs-Asian |
1.007190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61198999999446E-05 |
| Normal-vs-Female |
1.833840E-02 |
| Male-vs-Female |
1.480440E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.702300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.661600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.07909999999845E-05 |
| Normal-vs-Age(81-100Yrs) |
5.075700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.242600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.183200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.150600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.456630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.726800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.527800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.805200E-01 |
| Normal-vs-Grade 2 |
7.832000E-02 |
| Normal-vs-Grade 3 |
3.61720000000565E-05 |
| Normal-vs-Grade 4 |
2.51365595005382E-12 |
| Grade 1-vs-Grade 2 |
1.173780E-01 |
| Grade 1-vs-Grade 3 |
4.757600E-03 |
| Grade 1-vs-Grade 4 |
1.136490E-03 |
| Grade 2-vs-Grade 3 |
1.175180E-03 |
| Grade 2-vs-Grade 4 |
1.63713487211226E-12 |
| Grade 3-vs-Grade 4 |
3.16409999978617E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.691200E-01 |
| Normal-vs-ccB subtype |
8.86209994277465E-10 |
| ccA subtype-vs-ccB subtype |
1.71507252844094E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.835200E-04 |
| Normal-vs-N1 |
1.237730E-03 |
| N0-vs-N1 |
1.145650E-01 |
|
|
